Geron

4 followers

‌

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Industries

Biotechnology, Health & Wellness

Headquarters

Menlo Park, United States

Employees

201-500

Links

Org chart

John A. Scarlett

Chairman, President & CEO

John A. Scarlett

Collapse

Andrew J. Grethlein

EVP & COO

Edward Koval

EVP & Chief Business Officer

Michelle Robertson

Executive Vice President, CFO & Treasurer

Melissa A. Kelly Behrs

EVP, Business Operations & Chief Alliance Officer

Faye Feller

EVP, Chief Medical Officer

Jim Ziegler

EVP & Chief Commercial Officer

Joseph Eid

EVP, Research & Development

Scott A. Samuels

EVP, CLO & Corporate Secretary

Nishan Sengupta

Vice President-market Access, Pricing, Evidence Strategy

Scott Hutson

Vice President Of Sales

Ryan Vincenti

Associate Director Of Commercial Excellence

Teams

+17

Directors

20 members

+12

Clinical Operations Team

15 members

Medical and Clinical Teams

11 members

Leadership Team

5 members

Business Operations Team

6 members

Human Resources Team

6 members

Similar companies

CRISPR Therapeutics

9 followers

Arrowhead Pharmaceuticals

4 followers

33 followers

Headway

15 followers

Cerus

2 followers

ImmunityBio

2 followers

Aetion

8 followers

Virta

1 follower

Annexon Biosciences

2 followers

CVS Health

365 followers

Thermo Fisher Scientific

155 followers

Explore companies